(Q36825493)

English

A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM.

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM. (English)

1 reference

Europe PubMed Central

16 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

F Bressolle

1

1 reference

Europe PubMed Central

16 August 2017

C Bologna

2

1 reference

Europe PubMed Central

16 August 2017

L Edno

3

1 reference

Europe PubMed Central

16 August 2017

J C Bernard

4

1 reference

Europe PubMed Central

16 August 2017

R Gomeni

5

1 reference

Europe PubMed Central

16 August 2017

J Sany

6

1 reference

Europe PubMed Central

16 August 2017

B Combe

7

1 reference

Europe PubMed Central

16 August 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

16 August 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

16 August 2017

49

1 reference

Europe PubMed Central

16 August 2017

4

1 reference

Europe PubMed Central

16 August 2017

285-292

1 reference

Europe PubMed Central

16 August 2017

https://scigraph.springernature.com/pub.10.1007/bf00226329

0 references

Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Methotrexate in rheumatoid arthritis. An update

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Low-dose methotrexate kinetics in arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Some suggestions for measuring predictive performance

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Comparison of serum concentrations of methotrexate after various routes of administration

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology of methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimate of the number and of the temporal sequence of measurements in a kinetic experiment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental design and efficient parameter estimation in population pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal effects of low dose methotrexate in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of action of methotrexate in rheumatoid arthritis: the search continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal interaction between methotrexate and naproxen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate--the relationship between dose and clinical effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Pancytopenia during rheumatoid polyarthritis treated by low doses of methotrexate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00226329

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36825493&oldid=2143769376"